Friday, September 30, 2022


Biotechnology News Magazine

Emmanuelle Toussaint Named Executive Director of BIOQuébec

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

BIOQuébec’s Board of Directors is proud to announce the appointment of Emmanuelle Toussaint as Executive Director, effective immediately.

“We are very pleased to have Emmanuelle Toussaint join us as Executive Director. She is tremendously influential in the business community, and her diverse professional experiences, paired with her leadership, energy, and passion, will be greatly appreciated by BIOQuébec and our partners,” indicated Frédéric Leduc, President of the Board. “BIOQuébec has been supporting its members for over thirty years, and I firmly believe that Emmanuelle will take BIOQuébec to new heights.”

Emmanuelle Toussaint has over twenty-five years of management experience in both the private and public sectors. For many years, she held the position of Vice President, Legal, Regulatory & Public Affairs at Nova Bus and Prevost, which are part of the Volvo Group. She has also worked for various organizations in the manufacturing, medical, biotechnology, aerospace, municipal, and academic sectors.

A member of both the Barreau du Québec (the Quebec bar association) and the Ordre des administrateurs agréés du Québec (Quebec’s order of certified administrative professionals), Ms. Toussaint holds a bachelor’s degree in law and a certificate in administration from the Université Laval. A Chartered Administrator, she is also very involved in several business organizations and associations and a member of the board of directors and the executive committee of the Fédération des chambres de commerce du Québec (Quebec’s federation of chambers of commerce).

Emmanuelle Toussaint was named one of Canada’s 100 Most Powerful Women in 2021 by the Women’s Executive Network. She is also one of the recipients of Canada’s 2022 Clean50 Awards, which are presented by the Delta Management Group and recognize the 50 individuals who have contributed the most to the cause of sustainable development and clean capitalism in Canada over the past two years.

“I feel fortunate to be joining BIOQuébec, a Quebec association recognized as a true leader in its field, and I thank the members of the Board of Directors for their trust. This is a homecoming for me since I began my career in the biotechnology and life sciences sector. Quebec has a rich life sciences ecosystem, and the pandemic served to highlight the importance of having a strong value chain in this vital sector. I am thrilled to be involved in tackling this industry’s pivotal issues and to collaborate with all of BIOQuébec’s members and partners,” stated Emmanuelle Toussaint.

With Ms. Toussaint at its helm, BIOQuébec will continue to represent and support its members, namely biotechnology and life sciences companies, by speaking with government representatives on their behalf, fostering business development, and being a credible source of information for the community. BIOQuébec will address important issues in the coming months, such as the integration of innovations in the health system, access to data to facilitate medical research, the Patented Medicine Prices Review Board reforms, and the development of a coherent and concerted Canadian innovation strategy.

BIOQuébec is proud to contribute to the development of Quebec’s life sciences industry, a dynamic sector that creates wealth, skilled jobs, and innovations and aims to improve Quebecers’ health and quality of life. I would also like to thank Anie Perrault, who served as BIOQuébec’s Executive Director for the past few years and who did an outstanding job,” added Frédéric Leduc.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine